Literature DB >> 15188132

The role of beta-catenin, TGF beta 3, NGF2, FGF2, IGFR2, and BMP4 in the pathogenesis of mesenteric sclerosis and angiopathy in midgut carcinoids.

Paul J Zhang1, Emma E Furth, X Cai, John R Goldblum, Therisa L Pasha, K W Min.   

Abstract

A subset of midgut carcinoids (MCs) result in mesenteric angiopathy (MA) and bowel infarction as a consequence of vascular compression caused by extensive mesenteric sclerosis (MS). The goal of this study was to determine whether the level of expression of several fibrosing-related growth factors was related to the finding of MA and/or MS in MCs. Eighteen cases of MC, 6 with both extensive MS and MA (group I), 5 with extensive MS only (group II), and 7 with ordinary MS only (group III), were analyzed for immunoexpression of beta-catenin, transforming growth factor-beta 2 (TGF beta 2), nerve growth factor 2 (NGF2), fibroblast growth factor 2 (FGF2), insulin growth factor receptor (IGFR), and bone morphogenic protein 4 (BMP4) in formalin-fixed, paraffin-embedded sections. Standard immunohistochemical technique was used following antigen retrieval. Immunostaining was scored semiquantitively as the product of the percentage and intensity (0 to 2+) of the immunostaining, giving a possible range of 0 to 200. One-way analysis of variance and Mann-Whitney nonparametric analyses were used for statistical analysis. The mean scores of immunoreactivity of each factor in groups I, II, and III were as follows: 135, 174, and 147 for beta-catenin (cytoplasmic reactivity only); 106, 112, and 92 for TGF beta 3; 1.67, 32, and 36 for NGF-2; 2.5, 48, and 55 for FGF-2; 19, 112, and 66 for IGFR2; 140, 45, and 52 for BMP4. There were significant differences in NGF-2 immunoreactivity between groups I and III (P = 0.0023) and in BMP4 immunoreactivity between groups I and II (P = 0.017) and groups I and III (P = 0.022). All MCs expressed high levels of membranous beta-catenin, moderate levels of TGF beta 3 and IGFR2, and low levels of FGF-2, with no significant differences seen among the groups. MCs with prominent MS and MA (group I) expressed significantly higher BMP4 than those in groups II and III, suggesting a potential role of BMP4 in the pathogenesis of MA. The level of NGF-2 expression was significantly lower in group I than in group III, possibly indicating abnormal angiogenesis in the formation of angiopathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188132     DOI: 10.1016/j.humpath.2003.12.010

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  4 in total

1.  Expression of beta-catenin in gastroenteropancreatic endocrine tumours: a study of 229 cases.

Authors:  V Hervieu; F Lepinasse; G Gouysse; O Guillaud; C Barel; M-L Chambonniere; P-P Bringuier; G Poncet; C Lombard-Bohas; C Partensky; J-A Chayvialle; J-Y Scoazec
Journal:  J Clin Pathol       Date:  2006-05-26       Impact factor: 3.411

2.  Report from the 13th annual Western canadian gastrointestinal cancer consensus conference; calgary, alberta; september 8-10, 2011.

Authors:  M M Vickers; J Pasieka; E Dixon; S McEwan; A McKay; D Renouf; D Schellenberg; D Ruether
Journal:  Curr Oncol       Date:  2012-12       Impact factor: 3.677

Review 3.  What Causes Desmoplastic Reaction in Small Intestinal Neuroendocrine Neoplasms?

Authors:  Gowri M Ratnayake; Faidon-Marios Laskaratos; Dalvinder Mandair; Martyn E Caplin; Krista Rombouts; Christos Toumpanakis
Journal:  Curr Oncol Rep       Date:  2022-05-13       Impact factor: 5.945

4.  Connective tissue growth factor in tumor pathogenesis.

Authors:  Annica Jacobson; Janet L Cunningham
Journal:  Fibrogenesis Tissue Repair       Date:  2012-06-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.